Synthesis, Characterization, and Study of Drug Release Properties of Curcumin from Polycaprolactone /Organomodified Montmorillonite Nanocomposite

Journal of Pharmaceutical Innovation

Volumn 11, Issue 4, 2016, Pages 300-307

  Bakre, Lateef G ^a   Sarvaiya, Jayrajsinh I ^b   Agrawal, Yadvendra K ^b  

^a OLABISI ONABANJO UNIVERSITY   (Nigeria)

^b GUJARAT FORENSIC SCIENCES UNIVERSITY   (India)

Author keywords

Curcumin; Drug release kinetics; Montmorillonite; Nanodrug delivery system

Indexed keywords

BROMIDE; CURCUMIN; MONTMORILLONITE; N ACETYL N,N,N, TRIMETHYLAMMONIUM BROMIDE; NANOCOMPOSITE; POLYCAPROLACTONE; TRIMETHYLAMMONIUM SALT DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG RELEASE; DRUG SYNTHESIS; IN VITRO STUDY; NANOENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; ZETA POTENTIAL;

EID: 84976286775     PISSN: 18725120     EISSN: 19398042     Source Type: Journal    
DOI: 10.1007/s12247-016-9253-x     Document Type: Article

References (27)

1. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4:807–18.
2. Kuttan R, Bhanumathy P, Nirmala K, George MC. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett. 1985;29:197–202.
3. Kim MK, Choi GJ, Lee HS. Fungicidal property of Curcuma longa L. rhizome-derived curcumin against phytopathogenic fungi in a greenhouse. J Agric Food Chem. 2003;51:1578–81.
4. Reddy RC, Vatsala PG, Keshamouni VG, Padmanaban G, Rangarajan PN. Curcumin for malaria therapy. Biochem Biophys Res Commun. 2005;326:472–4.
5. Jordan WC, Drew CR. Curcumin—a natural herb with anti-HIV activity. J Natl Med Assoc. 1996;88:333.
6. Dikshit M, Rastogi L, Shukla R, Srimal RC. Prevention of ischaemia induced biochemical changes by curcumin and quinidine in the cat heart. Ind J Med Res. 1995;101:31–50.
7. Brouet I, Ohshima H. Curcumin, an anti-tumour promoter and antiimflammatory agent, inhibits induction of nitric oxide synthase inactivated macrophages. Biochem Biophys Res Commun. 1995;206:533–40.
8. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev. 2002;54:631–51.
9. Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL. The mechanism of uptake of biodegradable microparticles in CaCO-2cells is size dependant. Pharm Res. 1997;14:1568–73.
10. Lim KY, Kim BC, Yoon KJ. Structural and physical properties of biodegradable copolyesters from poly (ethylene terephthalate) and polycaprolactone. J Appl Polym Sci. 2003;88:131–8.
11. Gain O, Espuche E, Pollet E, Alexandre M, Dubois P. Gas barrier properties of poly (ecaprolactone)/clay nanocomposites: influence of the morphology and polymer/clay interactions. J Polym Sci Part B: Polymer Physics. 2005;43:205–14.
12. Saeed K, Park S. Preparation and properties of multiwalled carbon nanotube/polycaprolactone nanocomposites. J Appl Polym Sci. 2007;104:1957–63.
13. Kevadiya BD, Thumbar RP, Rajput MM, Rajkumar S, Brambhatt H, Joshi GV, et al. Montmorillonite/poly-(ε-caprolactone) composites as versatile layered material: reservoirs for anticancer drug and controlled release property. Eur J Pharm Sci. 2012;47:265–72.
14. Joshi GV, Kevadiya BD, Patel HA, Bajaj H, Jasra RV. Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate. Int J Pharm. 2009;374:53–7.
15. Sahoo S, Sasmal A, Sahoo D, Nayak PL. Synthesis and characterization of chitosan-polycaprolactone blended with organoclay for control release of doxycycline. J Appl Polym Sci. 2010;118:3167–75.
16. Mahesh KRV, Murthy HN, Kumaraswamy BE, Raghavendra N, Sridhar R, Krishna M, et al. Synthesis and characterisation of organo modified Na- MMT using cation and anion surfactant. Front Chem China. 2011;6:153–8.
17. Li X, Li R, Qian X, Ding Y, Tu Y, Guo R, et al. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate. Eur J Pharm Biopharm. 2008;70:726–34.
18. Xu G, Sunada H. Influence of formation changes on drug release kinetics. Chem Pharm Bull. 1995;43:483–7.
19. Ritger R, Peppas NA. A Simple equation for disposition of solute release-II. J Control Rel. 1987;5:37–42.
20. Higuchi T. Mechanism of sustained action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52:1145–9.
21. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2001;48:139–57.
22. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35.
23. Hoidy W, Ahmad M, Mulla A, Ibrahim NA. Synthesis and characterization of organoclay from sodium montmorillonite and fatty hydroxamic acids. Am J Appl Sci. 2009;6:1567–72.
24. Chorny M, Fishbein I, Danenberg HD, Golomb G. Lipophilic drug loaded nanospheres by nanoprecipitation: effect of formulationvariables on size, drug recovery and release kinetics. J Control Rel. 2002;83:389–400.
25. Mosqueira VCF, Legrana P, Pinto-Alphandary H, Puisieux F, Barratt B. Poly (d, l-lactide) nanocapsule prepared by a solventdisplacement process: influence of the composition on physicochemical and structural properties. J Pharm Sci. 2000;89:614–26.
26. Hedley CB, Yuan G, Theng BKG. Thermal analysis of montmorillonite modified with quaternary phosphonium and ammonium surfactants. Appl Clay Sci. 2007;35:180–8.
27. Suvakanta D, Padala NM, Lilakanta N, Prasanta C. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm - Drug Res. 2010;67(3):217–23.